An Economic Model for Determining the Costs and Consequences of Using Various Treatment Alternatives for the Management of Arthritis in Canada

This publication has 35 references indexed in Scilit:

• Healthcare Resource Utilisation and Costs of Treating NSAID-Associated Gastrointestinal Toxicity
  PharmacoEconomics, 2001
• THE RISKS AND COSTS OF UPPER GASTROINTESTINAL DISEASE ATTRIBUTABLE TO NSAIDS
  Gastroenterology Clinics of North America, 1996
• Nonsteroidal antiinflammatory drugs and dyspepsia in the elderly
  Digestive Diseases and Sciences, 1995
• Misoprostol coadministered with diclofenac for prevention of gastroduodenal ulcers
  Digestive Diseases and Sciences, 1995
• Prevention of NSAID-induced Gastroduodenal Mucosal Injury: Meta-Analysis of Clinical Trials with Misoprostol and H2-Receptor Antagonists
  Digestive Diseases, 1995
• Effect of Cimetidine on Gastrointestinal Symptoms in Patients Taking Nonsteroidal Anti-inflammatory Drugs:A large Double-blind Placebo Controlled Study
  Scandinavian Journal of Rheumatology, 1994
• Efficacy of 12 Months' Misoprostol as Prophylaxis against IMSAID-induced Gastric Ulcers:A placebo-controlled trial
  Scandinavian Journal of Rheumatology, 1994
• Double-blind comparison of efficacy and gastroduodenal safety of diclofenac/misoprostol, piroxicam, and naproxen in the treatment of osteoarthritis.
  Annals of the Rheumatic Diseases, 1993
• A Doubleblind Comparison of the Gastroduodenal Safety and Efficacy of Diclofenac and a Fixed Dose Combination of Diclofenac and Misoprostol in the Treatment of Rheumatoid Arthritis
  Scandinavian Journal of Rheumatology, 1992
• Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine.
  BMJ, 1988